Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Withdrawn 1Terminated 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 22Glioblastoma 15Gliosarcoma 13Prostatic Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Head and Neck Neoplasms 10Breast Neoplasms 10Pancreatic Neoplasms 9Lung Neoplasms 9Brain Neoplasms 7Adenocarcinoma of Lung 6Salivary Gland Neoplasms 5Astrocytoma 5Rectal Neoplasms 4Neoplasm Metastasis 4Glioma 4Central Nervous System Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Stomach Neoplasms 3Sarcoma 3Ovarian Neoplasms 3Oligodendroglioma 3Liver Neoplasms 3Colorectal Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Carcinoma, Hepatocellular 3Carcinoma, Ductal, Breast 3Wilms Tumor 2

Interventions

Cisplatin 16Cetuximab 16Radiotherapy, Intensity-Modulated 10Radiotherapy 7Docetaxel 7Fluorouracil 5Erlotinib Hydrochloride 5Everolimus 4Carboplatin 4Sorafenib 3Paclitaxel 3Fluorodeoxyglucose F18 3Chemotherapy, Adjuvant 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Ultrasonography 2Taxes 2Sirolimus 2Radiotherapy, Conformal 2Radiation 2Platinum 2Photochemotherapy 2Magnetic Resonance Spectroscopy 2Cryosurgery 2Celecoxib 2Biopsy 2Bevacizumab 21-phenyl-3,3-dimethyltriazene 21,2-diaminocyclohexaneplatinum II citrate 2temsirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Tongue Neoplasms × Radiotherapy, Conformal × Clear all
NCT00906360 2013-07-02

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

National Cancer Institute (NCI)

Phase 1 Terminated
36 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT01142414 2012-01-16

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡